Codes / ICD10CM / M1A.4

M1A.4 Other secondary chronic gout

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Other Secondary Chronic Gout

Summary

Other secondary chronic gout is a form of arthritis resulting from elevated uric acid levels due to an identifiable underlying condition or cause, leading to recurrent joint inflammation and potential tissue damage. It is characterized by persistent symptoms and may involve the formation of tophi (urate crystal deposits) in advanced stages.

Causes

Other secondary chronic gout arises from the body's inability to properly excrete uric acid, which can stem from an underlying condition or factor that disrupts uric acid metabolism or renal clearance. This leads to urate crystal deposition in joints and tissues, triggering inflammation over time.

Risk Factors

  • Underlying conditions that affect uric acid metabolism (e.g., certain hematologic disorders, enzyme deficiencies)
  • Medications that increase uric acid levels (e.g., some diuretics, chemotherapy agents)
  • Chronic kidney disease or renal impairment
  • History of gout or hyperuricemia
  • Exposure to substances that disrupt uric acid excretion

Symptoms

  • Recurrent episodes of intense joint pain, often in the big toe, ankles, or knees
  • Persistent swelling, redness, and warmth in affected joints
  • Formation of tophi (hard, painless lumps) under the skin
  • Stiffness and limited joint mobility
  • Flare-ups triggered by stress, diet, or illness

Diagnosis

Diagnosis involves a combination of clinical evaluation, laboratory tests, and imaging. Blood tests measure uric acid levels, while joint fluid analysis detects urate crystals. Imaging (e.g., X-rays or ultrasounds) assesses joint damage and tophi presence. Identifying the underlying cause of secondary gout is also critical for accurate diagnosis.

Treatment Options

  • Medications to reduce uric acid levels (e.g., allopurinol, febuxostat)
  • Non-steroidal anti-inflammatory drugs (NSAIDs) or corticosteroids for acute flare-ups
  • Lifestyle modifications to manage underlying conditions
  • Treatment of the primary cause contributing to uric acid elevation

Prognosis and Follow-Up

Prognosis depends on the underlying cause and adherence to treatment. Chronic management is often required to prevent flare-ups and complications. Regular follow-up with healthcare providers is essential to monitor uric acid levels, adjust medications, and address any emerging issues.

Complications

  • Chronic joint damage and deformity
  • Formation of tophi, which may ulcerate or become infected
  • Kidney stones or renal impairment due to uric acid accumulation
  • Increased risk of cardiovascular disease

Lifestyle & Prevention

  • Maintain a balanced diet low in purine-rich foods
  • Stay hydrated to support uric acid excretion
  • Limit alcohol consumption, particularly beer
  • Manage underlying conditions (e.g., kidney disease, hypertension)
  • Follow prescribed treatment plans consistently

When to Seek Professional Help

Seek medical attention if you experience severe joint pain, swelling, or redness, especially if symptoms persist or worsen. Prompt evaluation is important to prevent long-term joint damage and address underlying causes.

Tips for Medical Coders

When coding for other secondary chronic gout (M1A.4), ensure documentation supports the identification of an underlying cause or condition contributing to the elevated uric acid levels. Include details about the primary disorder, diagnostic findings, and treatment approaches to accurately reflect the clinical scenario. Verify that the code aligns with the specific secondary cause documented in the patient's record.

Book a walkthrough

M1A.4 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.